Published in Lab Business Week, May 13th, 2007
Elizabeth Posillico, Ph.D., President and CEO of Elusys Therapeutics, commented on the announcement, "This is a real honor and we are delighted that Anthim is counted among the 100 Great Investigational Drugs. I speak for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week